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Abstract: The key step in the syntheses of highly substituted trans-3,4-dihydroxypyrrolidines 
is introduction of bromide by stereospecific and regiospecific Hanessian-Hullar reactions; 
benzylidene lactones of L-rhamnonolactone and 6-deoxy-L-gulonolactone allow introduction 
of N at C2 with inversion or retention of configuration. Initially a protecting group, the 
benzylidene acetal then provides a bromide at C5 to allow formation of the pyrrolidine ring. 
With silyl protecting groups, bromide was introduced at C5 with inversion of configuration 
whereas benzoyl protection gave a mixture of retention and inversion, indicative of 
neighbouring group participation in a Hanessian-Hullar reaction. Four stereoisomeric 
pyrrolidines - iminosugar mimics of α- and β-L-rhamnulose and α- and β-6-deoxy-D-sorbose 
were prepared. Only the α-L-rhamnulose mimic showed moderate inhibition of rhamnosidase 
but some were good inhibitors of α-glucosidases; none inhibited rhamnose isomerase and they 
had a small effect as synthetic inducers of the rhamnose catabolic operon in E. coli.  
 
1. Introduction  
 
Hundreds of iminosugars,1 in which the ring oxygen of a monosaccharide has been replaced 
by nitrogen, have been isolated as natural products. Although one of the largest families of 
glycosidase inhibitors, iminosugars have many other bioactivities as sugar mimics. The 
glycosidase inhibition profiles of the 16 piperidine analogues of the 16 aldohexoses are quite 
well correlated with the structures of the parent sugars; however, the 10 pyrrolidine analogues 
of the 8 ketohexoses provide many surprises. 2  This paper describes the synthesis and 
preliminary evaluation of the α- 1 and β- 2 iminosugar analogues of rhamnulose and of their 
epimers at C5, α- 3 and β- 4, iminosugars analogues of 6-deoxy-D-sorbose, four of the sixteen 
pyrrolidine analogues of 6-deoxy ketohexoses [Figure 1]. An example of neighbouring group 




Figure 1: Iminosugar structures 
 
 6-Deoxy-DGDP (6-deoxy-2,5-dideoxy-2,5-imino-D-glucitol) 1D 3  and 6-deoxy-DMDP (6-
deoxy-2,5-dideoxy-2,5-imino-D-mannitol) 2D,4 the enantiomers of 1 and 2 respectively, have 
been isolated from Angylocalyx pynaertii.5 A further stereoisomer, a strong inhibitor of α-
fucosidase, was also isolated and ascribed the structure 4; the synthetic 4 prepared in this paper 
did not inhibit α-L-fucosidase. The natural product is therefore likely to be the enantiomer 4L, 
a fuculose analogue prepared previously by Wong.6 The rhamnulose analogues 2 and 4 may 
also be considered to be the α- and β-1-C-methyl analogues of LAB (1,4-dideoxy-1,4-imino-
L-arabinitol) 5, a potent and specific α-glucosidase inhibitor. 7  The glycosidase inhibition 
profiles of the new iminosugars are compared with structurally related iminosugars; their 
effects on rhamnose isomerase and the rhamnose operon were also investigated. 
 






The key step in the syntheses of the highly substituted trans-3,4-dihydroxypyrrolidines 1-4 was 
the introduction of bromide by a stereospecific and regiospecific Hanessian-Hullar reaction 
[Scheme 1].8 The benzylidene lactones 6 and 7, epimeric at C5, have only C2 OH unprotected 
and allow efficient access to the azidolactones 8-11. In general, displacement of a triflate at C2 
of a lactone by sodium azide in DMF can introduce nitrogen with either inversion or retention 
of configuration. Displacement of the 2-O-triflate in a γ-lactone in which all the ring 
substituents are cis gives a kinetic azide with a 2,3-trans relationship with the neighbouring 
oxygen; base catalysed isomerisation by azide gives the thermodynamically more stable azide 
in which all the substituents on the lactone ring are cis.9 The epimeric azides are always very 





Scheme 1: Synthetic strategy for trans-3,4-dihydroxypyrrolidines 1-4 
 
Reduction of the lactones to the corresponding diol, followed by silyl ether protection and 
oxidation with N-bromosuccinimide give the bromo-benzoates 12-15 with inversion of 
configuration at C5; the benzylidene acetal, initially a protecting group, subsequently allows a 
Hanessian-Hullar reaction to introduce the bromide leaving group at C5. When benzoate was 
substituted for silyl ether protection, both retained and inverted bromides were formed, 
indicating neighbouring group participation; the regiospecificity and stereoselectivity is 
discussed fully below. 
 
Reduction of the azides 12-15 to the corresponding amines allows cyclization to the 
pyrrolidines with a second inversion at C5. Deprotection of the pyrrolidines give the 
diastereomers 1-4 in an efficient and general approach, in which the configuration at C2 of the 
original sugar may be inverted or retained, but that at C5 is always retained.  
 
2.1.2 Synthesis of azidolactones 8, 9, 10 and 11 
 
For the rhamnonolactones 8 and 9, the benzylidene derivative 6 can readily be obtained from 
rhamnose in a one pot sequence on a 50 g scale11 [Scheme 2]. As previously described,12 the 
stable triflate 16, formed in 95% yield from 6, with sodium azide in DMF at -40 °C formed the 
kinetic glucono-azide 8 (75%) but at room temperature gave the thermodynamic mannono-
azide 9 (85%); the initially formed 8 was equilibrated to the more stable all cis-azide 9.  
 
 
Scheme 2: (i) (CF3SO2)2O, pyridine, THF, -20 °C, 95 %; (ii) NaN3, DMF, -40 °C, 75%; (iv) NaN3, 





Scheme 3: (i) PhCHO, conc HCl, 92%; (ii) (CF3SO2)2O, Pyridine, THF, -20 °C, 98%; (iii) NaN3, DMF, 
-10 °C, 20h, 77%; (iv) NaN3, DMF, rt, 78%, 42 h; (v) CF3CO2Cs, DMF, 60 °C, 100% 52 h ; (vi) 
(CF3SO2)2O, Pyridine, THF, -20 °C; (vii) NaN3, DMF, rt, 30 h, 45% (2 steps) 
 
For the synthesis of the idono- and gulono-azides 10 and 11, the starting material 6-deoxy-D-
gulonolactone 18 was prepared from the triacetonide 17 in 61% yield with no chromatography 
required; the route 13  is far more convenient than procedures from L-rhamnose12 or D-
gulonolactone (Scheme 3).14 Reaction of 18 with benzaldehyde in the presence of concentrated 
hydrochloric acid gave the crystalline lactone 7 (92%) in which the methyl group is equatorial. 
The stereochemistry of 7 was confirmed by the Nuclear Overhauser Effect (nOe) NMR 
analysis; significant 1,3-H nOe effects between the protons on the benzylidene ring showed the 
phenyl group to be equatorial in 7 in contrast to the axial phenyl substituent in the rhamnono-
epimer 6.15 
 
Esterification of the alcohol in 7 with triflic anhydride in THF in the presence of pyridine gave 
the stable triflate 19 (98%) which, on treatment with sodium azide in DMF at -10 °C for 20 h, 
gave the ido-azide 10 with inversion at C2 (77%); when the reaction was performed at room 
temperature for 42 h, the more stable gulo-azide 11 was isolated in 78% yield. The epimeric 
azides 10 and 11 were easily separated by chromatography. Both nucleophilic displacement by 
azide and the equilibration to the all cis-azide were much slower for the gulono-triflate 7 than 
for the analogous reactions of the rhamnono epimer 16. Displacement of the triflate 19 by 
caesium trifluoroacetate in DMF16 at 60 °C for 52 h gave the idono-lactone 20 (100%). The 
triflate 21 was unstable and substantially decomposed during isolation and treatment with 
sodium azide, giving 11 in poor yield (45%). The different behaviour between the mannono- 6 
and gulono- 7 lactones may be ascribed to substantially different conformations of the bicyclic 
acetals where the methyl group is, respectively, either axial or equatorial.15 In both the 
rhamnono- and gulono-series, efficient syntheses of the easily separable retained and inverted 
azides 8-11 can be obtained in good yield. 
 





Scheme 4: (i) DIBALH, DCM, -78 °C, then NaBH4, MeOH, 92% (2 steps); (ii) TBDMSOTf, pyridine, 
DCM, 98%; (iii) NBS, BaCO3, CCl4, reflux, 86%; (iv) Pd/C, H2, NaOAc, EtOH, 72%; (v) 
TFA/water/1,4-dioxane, 50 °C, then NaOH (2 M, aq), 50 °C, 81% (2 steps); (vi) DIBALH, DCM, -78 
°C, then NaBH4, MeOH, 89% (2 steps); (vii) TBDMSOTf, pyridine, DCM, 94%; (viii) NBS, BaCO3, 
CCl4, reflux, 92%; (ix) Pd/C, H2, NaOAc, EtOH, 71%; (x) TFA/water/1,4-dioxane, 50 °C, then NaOH 
(2 M, aq.), 50 °C, 64% (2 steps); 
 
The epimeric azides 8 and 9 derived from rhamnose were used for the synthesis of the α- 1 and 
β-2 iminosugar analogues of β-rhamnulose respectively [Scheme 4]. Reduction of 8 with 
DIBALH followed by in situ treatment with sodium borohydride gave the diol 22 (92%) which, 
with tert-butyldimethylsilyl (TBDMS) triflate in dichloromethane in the presence of pyridine, 
afforded the bis-silyl ether 23 (98%). The benzylidene acetal 23 with N-bromosuccinimide 
(NBS) in the presence of barium carbonate in carbon tetrachloride at reflux underwent a 
Hanessian-Hullar reaction to produce the bromide 12 in 1 h with inversion of configuration at 
C5 (86%). Hydrogenation of azide 12 in ethanol in the presence of sodium acetate gave the 
protected pyrrolidine 24 (72%), formed by closure of the resulting amine with a second 
inversion at C5. Removal of the silyl groups in 24 by trifluoroacetic acid, followed by 
hydrolysis of the benzoyl ester with aqueous sodium hydroxide and ion exchange purification, 
gave the unprotected L-gluco-pyrrolidine 1 (81%); no efficient conditions for global 
deprotection of 24 were found. The overall yield of 6-deoxy-L-DGDP 1 from benzylidene 
rhamnonolactone 6, with inversion at C2 and overall retention at C5, was 33%. 6-Deoxy-L-
DMDP 2 was formed in an identical sequence from benzylidene rhamnonolactone 6, with 
retention of configuration at both C2 and C5, in 29% overall yield [Scheme 4]. 
 





Scheme 5: (i) DIBALH, DCM, -78 °C, then NaBH4, MeOH, 66% (2 steps); (ii) TBDMSOTf, pyridine, 
DCM, 74%; (iii) NBS, BaCO3, CCl4, reflux, 99%; (iv) Pd/C, H2, NaOAc, EtOH; (v) TFA/water/1,4-
dioxane, 50 °C, then NaOH (2M, aq), 50 °C, 74% (3 steps from 14); (vi) LiBH4, THF, -20 °C, 90%; 
(vii) TBDMSOTf, pyridine, DCM, 84%; (viii) NBS, BaCO3, CCl4, reflux, 76%; (ix) Pd/C, H2, NaOAc, 
EtOH; (x) TFA/water/1,4-dioxane, 50 °C, then NaOH (2M, aq), 50 °C, 51% (3 steps from 15) 
 
The chemistry developed for the rhamnono-azidolactones proceeded equally reliably for the 6-
deoxy-gulonono-azidolactones and is summarised in Scheme 5. The overall yield of 6-deoxy-
D-ido-DMDP 3 was 36% from 10. Although usually the base-sensitivity of 2-azidolactones 
requires a two step reduction, the lactone 11 on treatment with lithium borohydride in THF 
gave the diol 31 in 90% yield; 6-deoxy-D-gulo-DMDP 4 was obtained in 29% overall yield 
from 11. 
 
2.1.4 Benzoate protection: neighbouring group participation (NGP) in the Hanessian- 
Hullar Reaction  
 
The Hanessian-Hullar reaction of either the benzylidene lactone 8 or the unprotected diol 22 
gave complex mixtures of products. As described above, treatment of the silyl ether 23 with N-
bromosuccinimide (NBS) in carbon tetrachloride in the presence of barium carbonate gave the 
bromide 12 in 86% yield [Scheme 6]. There is some uncertainty in the mechanism of the 
formation of the bromide 34.8 However, nucleophilic attack at C5 of the cation 35 is less 
hindered than attack at C3; additionally there are both β-oxygen and β-nitrogen substituents 
which slow SN2 displacement at C3. All the four diastereomeric silyl-protected ethers at C2 






Scheme 6: Neighbouring group participation (NGP) in Hanessian-Hullar reaction 
 
Benzoate was studied as an alternative protecting group. NBS oxidation of the dibenzoate 36 
[obtained by benzolation of the diol 22 (86%)] gave a mixture of the D-ido 39 and L-gluco- 40 
bromides in a 5:1 ratio and 91% yield. The cation 37 is thus mainly trapped by bromide in an 
SN2 inversion at C5 to give the ido-bromide 39. Competitive NGP by the benzoate at C4 in 37 
formed the cation 38 which undergoes attack by bromide to give a second inversion at C5 to 
form the gluco-bromide 40 with overall retention at C5; this may be the first report of NGP in 
a Hanessian-Hullar reaction. Both cations 37 and 38 undergo regiospecific nucleophilic 




Scheme 7: (i) BzCl, Pyridine, DCM, 86%; (ii) NBS, BaCO3, CCl4, reflux, 39:40 5:1, 91%; (iii) 
Pd/C, H2, NaOAc, EtOH, 41:42 4:1, 82%; (iv) NaOH (aq., 2M), 50 °C, 1:3 5:1, 73%. (v) BzCl, 
Pyridine, DCM, 97%; (vi) NBS, BaCO3, CCl4, reflux, 43:44 3:1, 94%; (vii) Pd/C, H2, NaOAc, 
EtOH, 45:46 10:7, 89%; (viii) NaOH (aq., 2M), 50 °C, 2:4 5:3, 70%. 
 
The inseparable bromides 39 and 40 [5:1] (91% from 36) on hydrogenation in the presence of 
palladium on charcoal in ethanol gave an inseparable epimeric mixture of the pyrrolidine 
tribenzoates 41 and 42 [4:1] (82%) [Scheme 7]. Removal of the benzoate protecting groups 
gave 1 and 3 (73%) in a ratio of 5:1, determined by comparison with 1H NMR of pure samples 
of 1 and 3 prepared as above. 
 
Benzoylation of the epimeric azidodiol 25 afforded the dibenzoate 26 (97%) which on 
treatment with NBS gave a mixture of the epimeric bromides 43 : 44, 3:1 (94%) which on 
hydrogenation gave the tribenzoates 45 : 46 (94%). Deprotection with aqueous sodium 
hydroxide gave a mixture of 2 : 4, 5:3 (94%). Again, none of the intermediate mixtures were 
separable. The use of silyl protection in Hanessian-Hullar reactions ensures there is no NGP, 
whereas other protecting groups may give epimeric bromides as products. 
 
 
3. Biological assays 
 
Compounds that affect enzymes in the biosynthesis and metabolism of L-rhamnose, a sugar 
that has no role in mammalian metabolism,17 have potential to affect pathogens and to provide 
novel antibiotics. 18 The effects of the rhamnulose mimics 1-4 on glycosidases, rhamnose 
isomerase and the rhamnose operon were investigated. 
 




Figure 2: Iminosugar structural relationships 
PLEASE KEEP CLOSE TO TABLE BELOW 
 
 
The inhibition of glycosidases by iminosugar furanose analogues is difficult to predict.2,19 The 
four trans-3,4-dihydroxypyrrolidines 1-4 prepared in this paper were compared with the 
corresponding iminosugars 47-49 in which the methyl group is replaced by a hydroxymethyl 
group20 [D-guloDMDP is identical by rotation to L-DGDP 47] as inhibitors of the following 
glycosidases21: α- and β-glucosidases (from various sources), α- and β-galactosidase, α- and 
β-mannosidase, α- L-fucosidase, α,α-trehalase, amyloglucosidase, α-L-rhamnosidase, and β-
glucuronidase (Table 1). L-DGDP 47 and L-DMDP 48 are the enantiomers of the natural 
products DGDP 47D [isolated from the Thai traditional medicine Non tai yak22 and a weak 
inhibitor of α-glucosidases] and DMDP 48D [a most abundant natural iminosugar23 and a 
potent inhibitor of β-galactosidase 2,24 ]. In contrast, their enantiomers L-DGDP 47 and L-
DMDP 48 are both specific and potent inhibitors of α-glucosidases;25 there are many cases in 
which enantiomers of iminosugars are more potent inhibitors of the same enzyme than the 
natural product. As 1 and 2 are the iminosugar mimics of α- and β-L-rhamnulose, L-DGDP 47 
and L-DMDP 48 are the corresponding mimics of α- and β-D-fructose.  
 
1. Only the α-rhamnulose mimic, 6-deoxy-L-DGDP, 1 showed moderate inhibition of α-
rhamnosidase. None of the other iminosugar hexose analogues – including the β-rhamnulose 
mimic 2 – showed any rhamnosidase inhibition. 6-Deoxy-L-DGDP 1 was also a moderate 
inhibitor of α-glucosidases; the substitution of Me in 1 for the CH2OH group in L-DGDP 47 
considerably reduced glucosidase and galactosidase inhibition. 6-deoxy-D-ido-DMDP 3, in 
which the methyl group is epimeric to that in 1, did not show significant inhibition of any 
glycosidase. 
 
2. 6-Deoxy-L-DMDP 2 was a potent and highly specific inhibitor of α-glucosidases. 
Comparison of 6-deoxy-L-DMDP 2 and L-DMDP 48 revealed that deoxygenation of C6-
OH group slightly increased the inhibition of rice and rat intestinal sucrase. Furthermore, 6-
deoxy-L-DMDP 2 lost inhibition of porcine kidney α,α-trehalase, showing more selectivity.  
 
3. 6-Deoxy-L-DMDP 2 was also compared to the potent and α-glucosidase inhibitor LAB 5. 
Its enantiomer DAB 5D, isolated from Angylocalyx boutiqueanus26 is a good inhibitor of α-
glucosidase and glycogen phosphorylase as a potential drug for the treatment of diabetes.27 
Although LAB 5 was 10-times better as an inhibitor of rat intestinal maltase than 6-deoxy-L-
DMDP 2, LAB 5 also showed broad inhibition toward α,α-trehalase and α-L-rhamnosidase. 
 
4. 6-Deoxy-D-gulo-DMDP 4, with its methyl group epimeric to that in 2, was a moderate [and 
highly specific] inhibitor of α-glucosidase. 2 and 4 may be viewed as the α- and β-1-C-methyl-
LAB derivatives. α-1-C-methyl-LAB 2 is a significantly more potent glucosidase inhibitor 
than its β-anomer 4. Broussonetines, a large family of natural glucosidase and galactosidase 
inhibitors, are α-1-C-alkyl-DAB derivatives.28 
 
 
3.2 Rhamnose Isomerase 
 
The only previous report of iminosugar inhibition of aldose isomerases is a crystallographic 
study of mimics of the substrates and products in the xylose isomerase catalyzed isomerization 
of glucose to fructose; DGDP 47D (an α-fructose mimic) was a weak inhibitor whereas DMDP 
48D (β-fructose mimic) showed no inhibition.29 There are no aldose isomerases in mammalian 
metabolism; no inhibitors of rhamnose isomerase have been described. 30  L-Rhamnose 
isomerase activity was measured by the conversion of L-rhamnose as substrate to L-rhamnulose 
as previously described.31 None of the four pyrrolidines 1-4 had any significant effect on the 
activity of rhamnose isomerase (for details, see Supplementary Material).  
 
3.3 Rhamnose Operon 
 
In synthetic biology, a precisely-controlled gene expression system based on the regulatory 
elements (transcriptional promoter and activator) of the L-rhamnose catabolism gene operon in 
E. coli, rhaBAD, has been frequently used for the production of various proteins.32 Free L-
rhamnose is an inducer of rhaBAD but has the significant disadvantage of being metabolized 
to rhamnulose, which causes induction of gene expression to cease. The performance of this 
promoter system would therefore be enhanced by the development of a non-metabolizable 
rhamnose substitute; some 35 rare sugars have been studied as potential alternative inducers to 
rhamnose.33 
 
The four iminosugars 1-4, tested for their ability to induce expression of the rhaBAD promoter 
in Escherichia coli cells using a reporter assay system33 showed much weaker induction than 
the nature inducer, L-rhamnose; the rhamnulose 1, 2 and 6-deoxy-L-sorbose 3 mimics had low 
but statistically significant induction of the rhaBAD promoter system (P < 0.05) relative to no 
inducer (see supplementary material). L-Rhamnose is easily metabolized in E. coli, causing 
gene expression to cease and a much reduced protein production. To overcome this problem, a 
non-metabolizable inducer is of both commercial and academic interest. The rhamnulose 
iminosugar analogues 1, 2 and 3, with no 6-hydroxyl group, are unlikely to be metabolized by 





The high yield syntheses of iminosugar mimics of L-rhamnulose and 6-deoxy-D-sorbose 
depended on (i) azide substitution of 2-O-triflates of lactones with either retention or inversion 
in consistent yields of >80%; and (ii) efficient Hanessian Hullar NBS oxidation of benzylidene 
acetals – silyl ether protection ensured bromide was introduced at C5 of the sugar with 
complete regio- and stereo-specificity whereas using benzoate as an alternative protecting 
group lead to a mixture arising from NGP. Only the α-L-rhamnulose mimic 1 showed moderate 
inhibition of rhamnosidase whereas 2 and 4 were good inhibitors of α-glucosidases; 2 and 4 
may be viewed as α- and β-1-C-methyl analogues of LAB 5, a potent α-glucosidase inhibitor. 
None inhibited rhamnose isomerase and they had only a small effect as synthetic inducers of 




5.1 General Experimental 
All commercial reagents were used as supplied. Solvents were used as supplied (Analytical or HPLC 
grade), without prior purification. Thin layer chromatography (TLC) was performed on aluminium 
sheets coated with 60 F254 silica. Plates were visualised using a 0.2% w/v cerium (IV) sulfate and 5% 
ammonium molybdate solution in 2 M sulfuric acid. Melting points were recorded on a Kofler hot block 
and are uncorrected. Optical rotations of the protected sugars were recorded on a Perkin-Elmer 241 
polarimeter with a path length of 1 dm; concentrations are quoted in g 100 mL-1. Optical rotations were 
recorded on a Jasco R1030 polarimeter, Na+ lamp, (Jasco, Tokyo, Japan) at 20 °C, polarimeter with a 
path length of 1 dm. Infrared spectra were recorded on a Perkin-Elmer 1750 IR Fourier Transform 
spectrophotometer using thin films on a diamond ATR surface (thin film). Only the characteristic peaks 
are quoted. Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AMX 500 (1H: 500 
MHz and 13C: 125.7 MHz) or Bruker AVIII 400 HD nanobay and Bruker DQX 400 (1H: 400 MHz, 13C: 
100.6 MHz) spectrometers in the deuterated solvent stated. 1H and 13C NMR spectra were assigned by 
utilizing 2D COSY, HSQC and HMBC spectra. All chemical shifts (δ) are quoted in ppm and coupling 
constants (J) in Hz. Residual signals from the solvents were used as an internal reference. For solutions 
in D2O acetonitrile was used as an internal reference. HRMS measurements were made using a 
microTOF mass analyzer using electrospray ionization (ESI) or an HP 5988A mass spectrometer using 
chemical ionization (CI).  
 
5.2 Azidogulonolactones 10 and 11 
 
(R)-3,5-O-Benzylidene-6-deoxy-D-gulono-1,4-lactone 7 
Concentrated hydrochloride acid (37%, 4 mL) was added to a suspension of 6-deoxy-D-gulono-1,4-
lactone 1812 (887 mg, 5.5 mmol) in benzaldehyde (15 mL). The reaction mixture was stirred at room 
temperature for 15 h during which time a solid product separated. The solid was collected by filtration 
and washed with diethyl ether (20 mL) to yield the benzylidene acetal 7 (1.2 g, 92%) as white crystals.  
HRMS (ESI+ve): found 273.0733 [M + Na]+; C13H14O5Na+ requires 273.0733; m.p. 226 - 230 °C; [α]D25 
-54 (c 0.8, MeCN); vmax (thin film): 1785 (s, C=O); δH (CD3CN, 500 MHz): 1.36 (3H, d, H6, J6,5 6.7), 
3.80 (1H, br-d, OH, JOH,2 8.9), 4.19 (1H, t, H4, J4,3 = J4,5 2.0), 4.25 (1H, dq, H5, J5,4 1.9, J5,6 6.6), 4.58 
(1H, dd, H2, J2,3 4.1, J2,OH 8.2), 4.68 (1H, dd, H3, J3,4 2.0, J3,2 4.1), 5.68 (1H, s, H7), 7.38 - 7.48 (5H, 
m, -Ar); δC (CD3CN, 100 MHz): 15.8 (C6), 71.4 (C2), 72.8 (C5), 72.1 (C4), 74.5 (C3), 98.9 (C7), 126.3, 
128.2, 129.1, 137.9 (-Ar), 175.4 (C=O); m/z (ESI+ve): 273 ([M + Na]+, 100%). 
 
(R)-3,5-O-Benzylidene-6-deoxy-2-O-trifluoromethanesulfonyl-D-gulono-1,4-lactone 19 
Anhydrous pyridine (0.3 mL, 0.36 mmol) and triflic anhydride (0.05 mL, 0.31 mmol) were sequentially 
added dropwise to a solution of the benzylidene lactone 7 (600 mg, 2.40 mmol) in anhydrous THF (10 
mL) at -20 °C. After 3 h, TLC (cyclohexane/ethyl acetate, 1:1) indicated the formation of one product 
(Rf 0.57). The reaction mixture was diluted with dichloromethane (10 mL) and washed with HCl (2 M, 
aq, 2 x 10 mL). The organic layer was dried (MgSO4); the solvent was removed in vacuo to give a 
residue that was purified by flash chromatography (ethyl acetate/cyclohexane, 1:5 to 1:2) to obtain pure 
triflate 19 (898 mg, 98%) as a white solid.  
HRMS (ESI+ve): Found 405.2226 [M + Na]+; C13H14O5Na+ requires 405.2226; m.p. 198 - 200 °C 
(decomp); [α]D25 -64 (c 0.79, MeCN); vmax (thin film): 1795 (s, C=O); δH (CD3CN, 400 MHz): 1.44 (3H, 
d, H6, J6,5 6.6), 4.36 (1H, dq, H5, J5,4 1.4, J5,6 6.6), 4.44 (1H, br-t, H4, J5,4 = J3,4 1.5), 5.12 (1H, dd, H3, 
J3,4 1.9, J3,2 4.0), 5.77 (1H, s, H7), 5.91 (1H, d, H2, J2,3 4.0), 7.44 - 7.46 (5H, m, -Ar); δC (CD3CN, 100 
MHz): 15.6 (C6), 71.4 (C5), 72.7, 72.8 (C3, C4), 80.2 (C2), 98.9 (C7), 126.1, 128.3, 129.3, 137.1 (-
Ar), 168.2 (C1); m/z (ESI+ve): 405 ([M + Na]+, 100%). 
 
2-Azido-(R)-3,5-O-benzylidene-2,6-dideoxy-D-idono-1,4-lactone 10 
Sodium azide (168 mg, 2.58 mmol) was added to a solution of triflate 19 (898 mg, 2.35 mmol) in 
anhydrous DMF (10 mL). The resulting solution was stirred at -10 °C for 20 h until TLC 
(cyclohexane/ethyl acetate, 1:1) indicated the formation of a major product (Rf 0.70). After dilution 
with ethyl acetate (10 mL), the reaction mixture was washed with half saturated brine (20 mL). The 
organic phase was dried (MgSO4), filtered and the solvent was removed in vacuo to obtain a residue 
that was purified by flash chromatography (ethyl acetate/cyclohexane, 1:7 to 1:5) to yield the idono-
azide 10 (500 mg, 77%) as a white solid. 
HRMS (ESI+ve): found 276.0980 [M + H]+; C13H14O4N3+ requires 276.0979; m.p.: 68 - 69 °C; [α]D25 -
89 (c 0.88, CHCl3); vmax (thin film): 2112 (s, N3), 1780 (s, C=O); δH (CDCl3, 400 MHz): 1.51 (3H, d, 
H6, J6,5 6.6), 4.20 (1H, dq, H5, J5,4 1.8, J5,6 6.6), 4.21 (1H, br-s, H4), 4.35 (1H, dd, H3, J3,4 1.9, J3,2 2.2), 
4.44 (1H, d, H2, J2,3 2.2), 5.65 (1H, s, H7), 7.37 - 7.45 (5H, m, -Ar); δC (CDCl3, 100 MHz): 17.5 (C6), 
63.3 (C5), 72.4 (C4), 76.1, 76.2 (C2, C3), 100.1 (C7), 126.5, 128.8, 129.9, 136.9 (-Ar), 171.4 (C1); m/z 
(ESI+ve): 298 ([M + Na]+, 100%). 
 
(R)-3,5-O-Benzylidene-6-deoxy-D-idono-1,4-lactone 20 
Caesium trifluoroacetate (48 mg, 0.19 mmol) was added to a solution of 10 (50 mg, 0.13 mmol) in 
anhydrous DMF (1.5 mL). The solution was then stirred at 60 °C for 50 h until TLC (ethyl 
acetate/cyclohexane, 2:1) indicated the disappearance of the starting material (Rf 0.68) and the 
formation of one product (Rf 0.62). After dilution with ethyl acetate (5 mL), the reaction mixture was 
washed with half saturated brine (10 mL). The organic phase was dried (MgSO4), filtered and the 
solvent was removed in vacuo to give a residue that was purified by flash chromatography (ethyl 
acetate/cyclohexane, 1:5 to 1:3) to obtain 20 (32.5 mg, 100%) as a white solid. 
HRMS (ESI+ve): found 273.0734 [M + Na]+; C13H14O5Na+ requires 273.0733; m.p. 82 - 84 °C; [α]D25 
-39 (c 0.78, CH3CN); νmax (thin film): 3220 (br, OH), 1776 (s, C=O); δH (CD3CN, 400 MHz): 1.39 (3H, 
d, H6, J6,5 6.6), 4.10 (1H, br-s, H3), 4.29 (1H, dq, H5, J5,4 1.7, J5,6 6.6), 4.51 – 4.53 (1H, m, H4), 5.68 
(1H, s, H7), 5.87 (1H, d, H2, J2,3 4.0), 7.37 - 7.44 (5H, m, -Ar); δC (CD3CN, 100 MHz): 17.3 (C6), 72.7 
(C5), 73.7 (C3), 76.9 (C4), 78.1 (C2), 99.8 (C7), 127.0, 129.1, 130.0, 138.8 (-Ar), 175.7 (C1); m/z 
(ESI+ve): 273 ([M + Na]+, 100%). 
 
2-Azido-(R)-3,5-O-benzylidene-2,6-dideoxy-D-gulono-1,4-lactone 11 
Method 1: from gulono-triflate 19 
Sodium azide (228 mg, 3.36 mmol) was added to a solution of the gulono-triflate 19 (838 mg, 2.19 
mmol) in anhydrous DMF (10 mL). The mixture was stirred at rt for 42 h until TLC (ethyl 
acetate/cyclohexane, 1:1) indicated the formation of major product (Rf 0.20). After being diluted with 
ethyl acetate (10 mL), the mixture was washed with half saturated brine (20 mL). The organic phase 
was dried (MgSO4), filtered and the solvent removed in vacuo to obtain a residue that was purified by 
flash chromatography (ethyl acetate/cyclohexane, 1:5 to 1:1) to yield the gulono-azide 11 (470 mg, 
78%) as a white solid, identical to material obtained by Method 2 below. 
Method 2: idono-lactone from 20 
Anhydrous pyridine (0.3 mL, 0.36 mmol) and triflic anhydride (0.5 mL, 0.31 mmol) were sequentially 
added dropwise to a solution of the idono-lactone 20 (60 mg, 0.24 mmol) in anhydrous THF (3 mL) at 
-20 °C. After 4 h, TLC (ethyl acetate/cyclohexane, 1:1) indicated the formation of the only product (Rf 
0.83). The reaction mixture was diluted with dichloromethane (5 mL) and washed with HCl (2 M, aq, 
2 x 5 mL). The organic layer was dried (MgSO4) and the solvent was removed in vacuo to give the 
residue (~100 mg) that was used without further purification; in contrast to gulono-triflate 21, this 
triflate was not stable. 
Sodium azide (23 mg, 0.36 mmol) was added to a solution of the crude triflate (~100 mg) in anhydrous 
DMF (2 mL). The mixture was stirred at rt for 30 h until TLC (ethyl acetate/cyclohexane, 1:1) indicated 
the formation of the product (Rf 0.20). After being diluted with ethyl acetate (5 mL), the mixture was 
washed with half saturated brine (10 mL). The organic phase was dried (MgSO4), filtered and the 
solvent was removed in vacuo to obtain a crude that was purified by flash chromatography (ethyl 
acetate/cyclohexane 1:5 to 1:1) to yield the azido lactone 11 as a white solid (30 mg, 45%). 
HRMS (ESI+ve): Found 298.0799 [M + Na]+; C13H13O4N3Na+ requires 298.0798; m.p. 144 - 148 °C; 
[α]D25 -76 (c 0.70, CHCl3); vmax (thin film): 2108 (s, N3), 1775 (s, C=O); δH (CDCl3, 400 MHz): 1.49 
(3H, d, H6, J6,5 6.6), 4.04 (1H, d, H2, J2,3 3.8), 4.14 (1H, br-s, H4), 4.22 (1H, dq, H5, J5,4 1.2, J5,6 6.6), 
4.78 (1H, dd, H3, J3,4 1.8, J3,2 3.8), 5.61 (1H, s, H7), 7.37 - 7.49 (5H, m, -Ar); δC (CDCl3, 100 MHz): 
17.0 (C6), 62.1 (C2), 72.5 (C5), 73.7 (C4), 75.2 (C3), 100.1 (C7), 126.5, 128.8, 129.8, 136.8 (-Ar), 
170.9 (C1); m/z (ESI+ve): 298 ([M + Na]+, 100%). 
 
5.3 6-Deoxy-L-DGDP 1 and 6-deoxy-L-DMDP 2 from rhamnono-azides 8 and 9 
 
2-Azido-(R)-3,5-O-benzylidene-2,6-dideoxy-L-glucitol 22 
Diisobutylaluminum hydride (25% w/v in toluene, 0.31 ml, 0.54 mmol) was added dropwise to a 
solution of the lactone 8 (100 mg, 0.36 mmol) in anhydrous dichloromethane (3.6 mL) at -78 °C. The 
reaction mixture was stirred at -78 °C for 1 h until mass spectrometry showed the formation of desired 
product peak ([M + Na]+ 300) and disappearance of the starting material peak ([M + Na]+ 298). The 
reaction mixture was diluted with ethyl acetate (15 mL) and potassium sodium tartrate (sat. aq., ~1 mL) 
was added. The reaction mixture was stirred for 8 h, then diluted with water (15 mL) and extracted with 
ethyl acetate (3 x 15 mL). The organic phase was dried (MgSO4) and the solvent was removed in vacuo; 
the residue was dissolved in methanol (3.6 mL) and then sodium borohydride (14 mg, 0.36 mmol) was 
added. After stirring the reaction mixture at rt for one h, TLC (ethyl acetate/cyclohexane, 2:3) showed 
the formation of a single spot (Rf 0.18). Acetic acid was added to neutralize the reaction mixture. The 
solvent was removed in vacuo and the residue was purified by flash column chromatography (ethyl 
acetate/cyclohexane, 3:7 to 1:1) to afford the diol 22 (93.6 mg, 92 %) as a white solid. 
HRMS (ESI+ve): found 302.1111 [M + Na]+; C13H17N3O4Na+ requires 302.1111; m.p. 105 - 106 °C; 
[α]D25 -5.2 (c 1.0, CH3CN); vmax (thin film): 3395 (br, OH), 2102 (s, N3); δH (CD3CN, 400 MHz): 1.49 
(3H, d, H6, J5,6 7.2), 3.42 (1H, br-t, OH, JOH,1 = JOH,1’ 5.5), 3.39 (1H, dt, H4, J4,3 = J4,5 1.2, J4,OH 9.5), 
3.53 (1H, d, OH, JOH,4 9.5), 3.57 - 3.66 (1H, m, H1), 3.68 - 3.78 (2H, m, H1’, H3), 4.17 - 4.27 (2H, m, 
H2, H5), 5.93 (1H, s, H7), 7.26 - 7.54 (5H, m, Ar); δC (CD3CN, 100 MHz): 15.4 (C6), 61.2 (C1), 65.5 
(C3), 67.2 (C4), 76.2 (C2), 76.8 (C5), 94.9 (C7), 127.3, 129.1, 129.7, 139.8 (-Ar); m/z (ESI+ve): 302 
([M + Na]+, 100%).  
 
2-Azido-(R)-3,5-O-benzylidene-1,4-bis-(O-tert-butyldimethylsilyl)-2,6-dideoxy-L-glucitol 23 
tert-Butyldimethylsilyl triflate (0.51 mL, 2.2 mmol) and anhydrous pyridine (0.22 mL, 2.7 mmol) were 
added to a solution of diol 22 (250 mg, 0.90 mmol) in anhydrous dichloromethane (6 mL) at 0 °C. After 
stirring at 0 °C for 1 h, the mixture was stirred at rt for another 3 h. TLC (ethyl acetate/cyclohexane, 
1:19) showed the formation of one spot (Rf 0.27). The solvent was removed in vacuo; the residue was 
dissolved in cyclohexane (25 mL) and washed with water (2 x 25 mL). Organic phase was dried 
(MgSO4), filtered and the solvent removed to obtain a residue that was purified by flash column 
chromatography (ethyl acetate/cyclohexane, 0:10 to 1:24) to afford the silyl ether 23 (444 mg, 98 %) as 
a white solid.  
HRMS (ESI+ve): found 530.2843 [M + Na]+; C25H45N3O4Si2Na+ requires 530.2841; m.p. 61 - 62 °C; 
[α]D25 -33.2 (c 1.0, MeCN); vmax (thin film): 2098 (s, N3); δH (CD3CN, 400 MHz): 0.13 (3H, s, CH3), 
0.14 (3H, s, CH3), 0.15 (3H, s, CH3), 0.18 (3H, s, CH3), 0.95 (9H, s, 3 x CH3), 0.96 (9H, s, 3 x CH3), 
1.44 (3H, d, H6, J6,5 7.2), 3.60 (1H, s, H4), 3.66 (1H, a-dt, H2, J2,1’ = J2,1 4.5, J2,3 8.8), 3.79 (1H, dd, H1, 
J1,2 4.5, Jgem 11.1), 3.87 (1H, dd, H1’, J1’,2 4.5, Jgem 11.1), 4.26 - 4.34 (2H, m, H3, H5), 5.94 (1H, s, H7), 
7.35 - 7.56 (5H, m, Ar); δC (CD3CN, 100 MHz): -4.9 (CH3), -5.0 (CH3), -3.9 (CH3), -3.2 (CH3), 16.1 
(C6), 19.2 (C(CH3)3), 19.3 (C(CH3)3), 26.6 (C(CH3)3), 26.7 (C(CH3)3), 63.4 (C1), 65.1 (C2), 69.1 (C4), 
75.6 (C3), 76.3 (C5), 95.3 (C7), 127.8, 129.5, 130.2, 140.6 (-Ar); m/z (ESI+ve): 530 ([M + Na]+, 100%). 
 
2-Azido-3-O-benzoyl-5-bromo-1,4-bis-(O-tert-butyldimethylsilyl)-2,5,6-trideoxy-D-iditol 12 
N-Bromosuccinimide (185 mg, 1.0 mmol) and barium carbonate (256 mg, 1.3 mmol) were added to a 
solution of 23 (440 mg, 0.87 mmol) in carbon tetrachloride (5.8 mL). The stirred reaction mixture was 
refluxed for 1 h until TLC (ethyl acetate/cyclohexane, 1:19) indicated the disappearance of starting 
material (Rf 0.27) and the formation of one major product (Rf 0.52). After removal of the solvent in 
vacuo, the residue was purified by flash column chromatography (ethyl acetate/hexane, 0:10 to 1:24) 
to give the bromide 12 (437 mg, 86%) as a colorless oil.  
HRMS (ESI+ve): found 586.2127, 588.2107 [M + H]+; C25H45BrN3O4Si2+ requires 586.2127, 588.2106; 
[α]D25 - 17.5 (c 1.0, MeCN); vmax (thin film): 1728 (s, C=O), 2102 (s, N3); δH (400 MHz, CD3CN): -0.08 
(3H, s, CH3), 0.02 (3H, s, CH3), 0.04 (3H, s, CH3), 0.13 (3H, s, CH3), 0.85 (9H, s, CH3), 0.88 (9H, s, 
CH3), 1.76 (3H, d, H6, J6,5 6.9), 3.77 - 3.86 (2H, m, H1, H2), 3.88 - 3.96 (1H, m, H1’), 4.08 (1H, dd, 
H4, J4,5 3.0, J4,3 6.6), 4.42 (1H, dq, H5, J5,4 3.0, J5,6 6.9), 5.54 (1H, dd, H3, J3,2 2.9, J3,4 6.6), 7.53 (2H, 
t, Ar, J 7.7), 7.67 (1H, t, Ar, J 7.4), 8.03 - 8.10 (2H, m, Ar); δC (100 MHz, CD3CN): -5.0 (CH3Si), -4.9 
(CH3Si), -3.2 (CH3Si), -3.1 (CH3Si), 19.1 (C(CH3)3), 19.2 (C(CH3)3), 23.9 (C6), 26.5 (C(CH3)3), 26.6 
(C(CH3)3), 53.3 (C5), 63.4 (C2), 64.8 (C1), 75.3 (C4), 75.8 (C3), 130.0, 131.1, 131.2, 134.8 (Ar), 166.7 
(C=O); m/z (ESI+ve): 586, 588 ([M + H]+, 100%, 93%). 
 
3-O-Benzoyl-1,4-bis-(O-tert-butyldimethylsilyl)-2,5-imino-2,5,6-trideoxy-L-glucitol 24 
Palladium on charcoal (10 % wt., 72 mg) and sodium acetate (84 mg, 1.0 mmol) were added to a solution 
of 12 (399 mg, 0.68 mmol) in ethanol (20 mL). The reaction mixture was flushed sequentially with 
nitrogen, argon and hydrogen gas and stirred vigorously overnight at rt under a hydrogen atmosphere 
until TLC (ethyl acetate/cyclohexane, 3:7) showed the formation of one major product (Rf 0.32). After 
filtration, the solvent was removed in vacuo and the residue purified by flash column chromatography 
(triethylamine/ethyl acetate/cyclohexane, 0.01:3:7) to afford 24 (236 mg, 72%) as a yellow oil. 
HRMS (ESI+ve): found 480.2957 [M + H]+; C25H45NO4Si2+ requires 480.2960; [α]D25 +17.4 (c 1.0, 
MeCN); vmax (thin film): 1722 (s, C=O); δH (CD3CN, 400 MHz): -0.09 (3H, s, CH3), -0.05 (3H, s, CH3), 
0.05 (3H, s, CH3), 0.09 (3H, s, CH3), 0.82 (9H, s, CH3), 0.88 (9H, s, 3 x CH3), 1.18 (3H, d, H6, J6,5 6.4), 
2.98 (1H, quintet, H5, J5,4 6.3), 3.45-3.51 (1H, m, H2), 3.60 (1H, dd, H1, J1,2 4.9, Jgem 10.1), 3.68 (1H, 
dd, H1’, J1’,2 6.6, Jgem 10.1), 3.88 (1H, dd, H4, J4,3 4.2, J4,5 6.3), 5.27 (1H, dd, H3, J3,4 4.2, J3,2 6.2), 7.50-
7.56 (2H, m, Ar), 7.59 - 7.64 (1H, m, Ar), 8.05 - 8.07 (2H, m, Ar); δC (CD3CN, 100 MHz): -5.1 (CH3), 
-5.0 (CH3), -4.1 (CH3), -3.9 (CH3), 18.9 C(CH3)3, 19.1 (C(CH3)3), 20.0 (C6), 26.5 (C(CH3)3), 26.6 
(C(CH3)3), 60.6 (C5), 61.3 (C2), 63.5 (C1), 82.3 (C3), 84.0 (C4), 129.9, 130.8, 131.6, 134.6 (Ar), 167.0 
(C=O); m/z (ESI+ve): 480 ([M + H]+, 100%). 
 
2,5-Imino-2,5,6-trideoxy-L-glucitol (6-Deoxy-L-DGDP) 1 
24 (236 mg, 0.49 mmol) was dissolved in a mixture of trifluoroacetic acid/water/1,4-dioxane (1:1:1, 6 
mL). The solution was stirred at 50 °C for 24 h until mass spectrometry showed the deprotection of the 
silyl groups ([M + H]+ 252). The solvent was removed in vacuo; the residue was dissolved in aqueous 
sodium hydroxide (aq., 2 M, 10 mL) and stirred at 50 °C for 24 h until mass spectrometry showed the 
formation of desired product ([M + H]+ 148). After removal of the solvent in vacuo, the residue was 
dissolved in ethanol (5 mL), filtered and then loaded with water (~1 mL) onto a short column of 
DOWEX® 50WX8-200 resin (pre-washed with water, 1,4-dioxane and water sequentially until the 
eluent was neutral). The ion exchange column was then washed with water, 1,4-dioxane and then water 
and the pure product was then eluted with aqueous ammonia (2 M). Removal of the solvent in vacuo 
gave the unprotected pyrrolidine 1 as a yellow oil (58 mg, 81%). 
HRMS (ESI+ve): found 148.0967 [M + H]+; C6H14NO3+ requires 148.0968; [α]D25 –12.1 (c 0.45, water) 
[lit.34 for 1D,the enantiomer of 1: [α]D29 +5.2 (c 1.0, MeOH)]; vmax (thin film): 3300 (br, NH, OH); δH 
(D2O, 400 MHz): 1.25 (3H, d, H6, J6,5 6.6), 2.92 (1H, quintet, H5, J5,4 = J5,6 6.6), 3.05 (1H, q, H2, J2,1 
= J2,1’ = J2,3 6.0), 3.64 (1H, dd, H4, J4,3 3.5, J4,5 6.6), 3.67 (1H, dd, H1, J1,2 6.0, Jgem 11.4), 3.79 (1H, dd, 
H1’, J1’,2 6.0, Jgem 11.4), 4.12 (1H, dd, H3, J3,4 3.5, J3,2 6.0); δC (D2O, 100 MHz): 17.9 (C6), 59.2 (C5), 
60.6 (C1), 61.2 (C2), 78.3 (C3), 84.4 (C4); m/z (ESI+ve): 148 ([M + H]+, 100%). 
 
2-Azido-(R)-3,5-O-benzylidene-2,6-dideoxy-L-mannitol 25 
Diisobutylaluminium hydride (25% w/v in toluene, 2.33 ml, 4.05 mmol) was added dropwise to a 
solution of 9 (500 mg, 1.80 mmol) in anhydrous dichloromethane (18 mL) at -78 °C. The solution was 
stirred at -78°C for 1.5 h until mass spectrometry showed the formation of desired product peak ([M + 
Na]+ 300) and disappearance of starting material peak ([M+Na]+ 298). Then the mixture was diluted 
with ethyl acetate (25 mL) and potassium sodium tartrate (sat, aq., ~5 mL) was added and allowed to 
stand at rt for 8h. The reaction mixture was diluted with water (50 mL) and extracted with ethyl acetate 
(3 x 50 mL). Organic phase was dried (MgSO4), filtered and solvent was removed in vacuo to obtain a 
residue that was dissolved in methanol (18 mL) and sodium borohydride (69 mg, 1.80 mmol) was 
added. After stirring at rt for one h, TLC (ethyl acetate/cyclohexane, 2:3) showed the formation of a 
single spot (Rf 0.32). Acetic acid was added to neutralize the reaction mixture. After removing the 
solvent in vacuo, the crude product was purified by flash column chromatography (ethyl 
acetate/cyclohexane, 3:7 to 1:1) to afford the diol 25 (452 mg, 89 %) as a white solid. 
HRMS (ESI+ve): found 302.1111 [M + Na]+; C13H17N3O4Na+ requires 302.1111; m.p. 108 - 109 °C; 
[α]D25 +19.8 (c 1.0, MeCN); vmax (thin film): 3406 (br, OH), 2102 (s, N3); δH (CD3CN, 400 MHz): 1.44 
(3H, d, H6, J6,5 7.2), 3.11 (1H, br-t, OH, JOH,1 = JOH,1’ 5.7), 3.43 - 3.51 (2H, m, H4, OH), 3.65 (1H, dt, 
H1, J1,2 5.9, Jgem 11.8), 3.73 (1H, ddd, H2, J2,1’ 2.6, J2,1 5.9, J2,3 9.1), 3.88 (1H, ddd, H1’, J1’,2 2.6, J1’,OH 
5.7, Jgem 11.8), 4.01 (1H, d, H3, J3,2 9.1), 4.26 (1H, q, H5, J5,6 7.2), 5.85 (1H, s, H7), 7.33 - 7.53 (5H, 
m, Ar); δC (CD3CN, 100 MHz): 15.2 (C6), 62.4 (C1), 63.4 (C2), 66.8 (C4), 73.9 (C3), 76.9 (C5), 94.7 
(H7), 127.2, 129.1, 129.7, 139.8 (Ar); m/z (ESI+ve): 302 ([M + Na]+, 100%). 
 
2-Azido-(R)-3,5-O-benzylidene-1,4-bis-(O-tert-butyldimethylsilyl)-2,6-dideoxy-L-mannitol 26 
tert-Butyldimethylsilyl triflate (1.0 mL, 4.50 mmol) and anhydrous pyridine (0.45 mL, 5.4 mmol) were 
added to a solution of 25 (500 mg, 1.80 mmol) in anhydrous dichloromethane (12 mL) at 0 °C. After 
stirring at 10 °C for 3 h, TLC (ethyl acetate/cyclohexane, 1:4) showed the formation of a new spot (Rf 
0.73) but reaction was not complete. Further tert-butyldimethylsilyl triflate (0.33 mL, 1.49 mmol) and 
anhydrous pyridine (0.15 mL, 1.80 mmol) were added to the reaction mixture which was stirred at -18 
°C for 16 h until TLC indicated the completion of reaction. After removing the solvent in vacuo, the 
residue was dissolved in ethyl acetate (50 mL) and washed with half saturated brine (50 mL) and then 
brine (50 mL). The organic phase was dried (MgSO4), filtered and solvent was removed to obtain a 
residue that was purified by flash column chromatography (ethyl acetate/cyclohexane, 0:10 to 1:4) to 
afford 26 (852 mg, 94 %) as a colorless oil.  
HRMS (ESI+ve): found 530.2838 [M + Na]+; C25H45N3O4Si2Na+ requires 530.2841; [α]D25 +7.6 (c 1.0, 
MeCN); vmax (thin film): 2099 (s, N3); δH (CD3CN, 400 MHz): 0.08 (6H, s, CH3), 0.150 (3H, s, CH3), 
0.153 (3H, s, CH3), 0.92 (9H, s, 3 x CH3), 0.95 (9H, s, 3 x CH3), 1.41 (3H, d, H6, J6,5 7.2), 3.63 (1H, 
br-s, H4), 3.66 (1H, ddd, H2, J2,1’ 1.9, J2,1 5.0, J2,3 7.5), 3.87 (1H, dd, H1, J1,2 5.0, Jgem 10.9), 4.01 (1H, 
dd, H3, J3,4 1.1, J3,2 7.5), 4.06 (1H, dd, H1’, J1’,2 1.9, Jgem 10.9), 4.25 (1H, q, H5, J5,6 7.2), 5.80 (1H, s, 
H7), 7.32 - 7.47 (5H, m, Ar); δC (CD3CN, 100 MHz): -5.3 (CH3Si), -5.3 (CH3Si), -4.7 (CH3Si), -4.2 
(CH3Si), 15.4 (C6), 18.79 (C(CH3)3), 18.84 (C(CH3)3), 26.1 (C(CH3)3), 26.2 (C(CH3)3), 62.1 (C2), 64.1 
(C1), 67.8 (C4), 73.3 (C3), 76.2 (C5), 94.5 (C7), 127.2, 129.0, 129.7, 140.1 (Ar); m/z (ESI+ve): 530 
([M + Na]+, 100%). 
 
2-Azido-3-O-benzoyl-5-bromo-1,4-bis-(O-tert-butyldimethylsilyl)-2,5,6-trideoxy-D-gulitol 13 
N-Bromosuccinimide (358 mg, 2.0 mmol) and barium carbonate (496 mg, 2.5 mmol) were added to a 
solution of 26 (851 mg, 1.70 mmol) in carbon tetrachloride (11.2 mL). The mixture was refluxed with 
stirring for 50 min until TLC (ethyl acetate/cyclohexane, 1:19) indicated the disappearance of starting 
material (Rf 0.50) and the formation of one major product (Rf 0.62). After removal of the solvent in 
vacuo, the residue was purified by flash column chromatography (ethyl acetate/hexane 0:10 to 1:24) to 
afford 13 (909 mg, 92%) as a colorless oil.  
HRMS (ESI+ve): found 608.1944, 610.1924 [M + Na]+; C25H44BrN3O4Si2Na+ requires 608.1946, 
608.1926; [α]D25 -22.2 (c 1.0, MeCN); vmax (thin film): 2098 (s, N3), 1728 (s, C=O); δH (CD3CN, 400 
MHz): 0.05 (3H, s, CH3), 0.06 (3H, s, CH3), 0.08 (3H, s, CH3), 0.16 (3H, s, CH3), 0.91 (9H, s, 3 x CH3), 
0.93 (9H, s, 3 x CH3), 1.66 (3H, d, H6, J6,5 6.9), 3.79 - 3.91 (2H, m, H1, H2), 3.96 (1H, dd, H1’, J1’,2 
3.7, Jgem 10.0), 4.21 (1H, t, H4, J4,3 = J4,5 4.0), 4.34 (1H, dq, H5, J5,4 4.0, J5,6 6.9), 5.60 (1H, dd, H3, J3,4 
4.0, J3,2 6.3), 7.49 - 7.57 (2H, m, -Ar), 7.63 - 7.70 (1H, m, -Ar), 8.01 - 8.09 (2H, m, -Ar); δC (CD3CN, 
100 MHz): -5.1 (CH3Si), -5.0 (CH3Si), -3.5 (CH3Si), -3.3 (CH3Si), 19.1 (C(CH3)3), 22.5 (C6), 26.4 
(C(CH3)3), 26.5 (C(CH3)3), 52.9 (C5), 63.5 (C2), 64.0 (C1), 73.8 (C3), 74.6 (C4), 130.0, 130.9, 131.2, 
134.8 (-Ar), 166.4 (C=O); m/z (ESI+ve): 586, 588 ([M + H]+, 100%, 97%). 
 
3-O-Benzoyl-1,4-bis-(O-tert-butyldimethylsilyl)-2,5-imino-2,5,6-trideoxy-L-mannitol 27 
Palladium on charcoal (10 % wt., 165 mg) and sodium acetate (191 mg, 2.3 mmol) were added to a 
solution of 13 (909 mg, 1.5 mmol) in ethanol (45 mL). The reaction mixture was flushed with nitrogen, 
argon and hydrogen gas sequentially. Then the reaction mixture was stirred vigorously overnight at rt 
under a hydrogen atmosphere for 12 h until TLC (ethyl acetate/cyclohexane, 1:4) showed the formation 
of one major product (Rf 0.17). Filtration and evaporation in vacuo gave a crude bromide salt (~1.2 g). 
Part of the salty residue (120 mg) was purified by flash column chromatography (triethylamine/ethyl 
acetate/cyclohexane, 0.01:3:7) to give a pure sample of 27 (64 mg, 71%) as a yellow oil for full 
characterization. The crude salt was used in the next step. 
HRMS (ESI+ve): found 480.2959 [M + H]+; C25H45NO4Si2+ requires 480.2960; [α]D25 +10.6 (c 1.0, 
MeCN); vmax (thin film): 3350 (br, NH), 1722 (s, C=O); δH (CD3OD, 400 MHz): 0.00 (3H, s, CH3), 0.09 
(3H, s, CH3), 0.09 (3H, s, CH3), 0.13 (3H, s, CH3), 0.84 (9H, s, 3 x CH3), 0.91 (9H, s, 3 x CH3), 1.29 
(3H, d, H6, J6,5 6.6), 3.32 - 3.46 (2H, m, H2, H5), 3.81 (1H, dd, H1, J1,2 3.9, Jgem 10.6), 4.00 (1H, dd, 
H1’, J1’,2 4.4, Jgem 10.6), 4.13 (1H, dd, H4, J4,3 5.2, J4,5 7.3), 5.29 (1H, t, H3, J3,2 = J3,4 4.6), 7.48 (2H, t, 
-Ar, J 7.7), 7.61 (1H, t, -Ar, J 7.4), 8.04 (2H, d, -Ar, J 7.4); δC (CD3OD, 100 MHz): -5.3 (CH3Si), -5.2 
(CH3Si), -4.6 (CH3Si), -4.2 (CH3Si), 17.1 (C6), 18.7 (C(CH3)3), 19.1 (C(CH3)3), 26.2 (C(CH3)3), 26.4 
(C(CH3)3), 60.2 (C5), 64.0 (C2), 64.7 (C1), 82.8 (C3), 83.3 (C4), 129.7, 130.7, 130.8, 134.6 (Ar), 167.4 
(C=O); m/z (ESI+ve): 480 ([M + H]+, 100%). 
 
2,5-Imino-2,5,6-trideoxy-L-mannitol (6-Deoxy-L-DMDP) 2 
The crude product 27 (617 mg) was dissolved in a solution of trifluoroacetic acid/water/1,4-dioxane 
(2:1:1, 20 mL). The solution was stirred at 50 °C for 18 h until mass spectrometry showed the 
deprotection of the silyl groups ([M + H]+ 252). After the solvent was removed in vacuo, the residue 
was dissolved into sodium hydroxide solution (aq, 2M, 5 mL) and stirred at 50 °C for 24 h until mass 
spectrometry showed the formation of desired product ([M + H]+ 148). The mixture was neutralized 
with HCl (2M, aq) and the solvent removed in vacuo. The residue was dissolved in ethanol (5 mL) and 
filtered (glass microfiber) to afford a crude salt that was then loaded with water (~1 mL) onto a short 
column of DOWEX® 50WX8-200 resin. The ion exchange column was then washed with water, 1,4-
dioxane and then water; the pure product was then eluted with aqueous ammonia (2 M). Removal of 
solvent in vacuo gave a residue which was subjected to a further purification cycle by resin column to 
yield 6-deoxy-L-DMDP 2 as a yellow oil (121 mg, 64% from crude salt of 27). 
HRMS (ESI+ve): found 148.0968 [M + H]+; C6H13NO3+ requires 148.0968; [α]D25 -42 (c 1.0, MeOH) 
[lit.35 [α]D25 -33 (c 1.2, MeOH)]; vmax (thin film): 3277 (br, NH, OH); δH (D2O, 400 MHz): 1.19 (3H, d, 
H6, J6,5 6.4), 2.96 (1H, dq, H5, J5,6 6.4, J5,4 7.3), 3.05 (1H, br-q, H2, J 6.5), 3.58 – 3.64 (2H, m, H4, 
H1), 3.68 (1H, dd, H1’, J1’,2 4.6, Jgem 11.4), 3.81 (1H, t, H3, J3,4 = J3,2 6.8); δC (D2O, 100 MHz): 17.8 
(C6), 58.2 (C5), 62.0, 63.0 (C1, C2), 78.7 (C3), 83.3 (C4); m/z (ESI+ve): 148 ([M + H]+, 100%); m/z 
(ESI+ve): 148 ([M + H]+, 100%).  
 
5.4 6-Deoxy-D-ido-DMDP 3 and 6-deoxy-D-gulo-DMDP 4 from D-gulono-azides 10 and 11 
 
2-Azido-(R)-3,5-O-benzylidene-2,6-dideoxy-D-iditol 28 
Diisobutylaluminium hydride (25% w/v in toluene, 4.83 ml, 8.50 mmol) was added dropwise to a 
solution of 10 (467 mg, 1.70 mmol) in anhydrous dichloromethane (15 mL) at -78 °C. The reaction 
mixture was stirred at -78 °C for 3 h until mass spectrometry showed the formation of desired product 
peak ([M+Na]+ 300) and disappearance of starting material peak ([M + Na]+ 298). Then the mixture 
was diluted with ethyl acetate (20 mL) and potassium sodium tartrate (sat, aq., ~2 mL) was added. After 
stirring for 12 h, the mixture was diluted with water (30 mL) and extracted with ethyl acetate (3 x 20 
mL). Organic phase was dried (MgSO4), filtered and solvent was removed in vacuo to obtain a residue 
that was dissolved in methanol (15 mL) and sodium borohydride (84 mg, 2.20 mmol) was added. After 
stirring at rt for one h, TLC (ethyl acetate/cyclohexane, 1:1) showed the formation of a new spot (Rf 
0.32). Acetic acid was added to neutralize the reaction mixture. The solvent was removed in vacuo, the 
resulting crude was purified by flash column chromatography (ethyl acetate/cyclohexane, 1:4 to 1:1) to 
afford the ido-diol 28 (312 mg, 66 %) as a pale syrup. 
HRMS (ESI+ve): Found 302.1111 [M + Na]+; C13H17O4N3Na+ requires 302.1111; [α]D25 +5.2 (c 0.78, 
CHCl3); vmax (thin film): 3400 (br, OH), 2108 (s, N3); δH (CDCl3, 400MHz): 1.37 (3H, d, H6, J6,5 6.4), 
2.24 (1H, br-s, OH), 3.48 (1H, br-s, H4), 3.76 (1H, dd, H1, J1,2 4.2, Jgem 12.0), 3.82 (1H, dd, H1’, J1’,2 
3.1, Jgem 12.0), 3.90 (1H, ddd, H2, J2,1’ 3.1, J2,1 4.2, J2,3 8.5), 4.06 (1H, dq, H5, J5,4 0.6, J5,6 6.5), 4.35 
(1H, dd, H3, J3,4 0.6, J3,2 8.5), 5.69 (1H, s, H7), 7.36 - 7.56 (5H, m, -Ar); δC (CDCl3, 100MHz): 17.2 
(C6), 61.2 (C1), 64.3 (C2), 66.6 (C4), 76.6 (C5), 81.5 (C3), 101.4 (C7), 126.1, 128.6, 129.3, 137.6 (-
Ar); m/z (ESI+ve): 302 ([M + Na]+, 100%). 
 
2-Azido-(R)-3,5-O-benzylidene-1,4-bis-(O-tert-butyldimethylsilyl)-2,6-dideoxy-D-iditol 29 
tert-Butyldimethylsilyl triflate (1.03 mL, 4.5 mmol) and anhydrous pyridine (0.59 mL, 7.2 mmol) were 
added to a solution of 28 (250 mg, 0.90 mmol) in anhydrous dichloromethane (6 mL) at 0 °C. Then the 
mixture was stirred at rt for 18 h until TLC (ethyl acetate/cyclohexane, 1:4) showed the formation of a 
major spot (Rf 0.78). Removal of the solvent in vacuo gave a residue that was dissolved in cyclohexane 
(25 mL) and washed with water (2 x 25 mL). The organic phase was dried (MgSO4), filtered and the 
solvent removed to obtain a residue that was purified by flash column chromatography (ethyl 
acetate/cyclohexane, 1:9) to afford the fully protected 29 (334 mg, 74 %) as a colorless oil.  
HRMS (ESI+ve): found 530.2840 [M + Na]+; C25H45N3O4Si2Na+ requires 530.2841; [α]D25 -35 (c 0.81, 
CHCl3); vmax (thin film): 2100 (s, N3); δH (CDCl3, 400 MHz): 0.10 (3H, s, CH3), 0.11 (6H, s, 2 x CH3), 
0.15 (3H, s, CH3), 0.92 (9H, s, 3 x CH3), 0.97 (9H, s, 3 x CH3), 1.31 (3H, d, H6, J6,5 6.4), 3.56 (1H, br-
s, H4), 3.60 (1H, ddd, H2, J2,1’ 3.2, J2,1 4.6, J2,3 9.0), 3.75 (1H, dd, H1, J1,2 4.6, Jgem 10.7), 3.82 (1H, dd, 
H1’, J1’,2 3.1, Jgem 10.7), 3.92 (1H, q, H5, J5,6 6.5), 4.00 (1H, d, H3, J3,2 9.0), 5.62 (1H, s, H7), 7.33 - 
7.55 (5H, m, -Ar); δC (CDCl3, 100 MHz): -5.2 (CH3Si), -5.1 (CH3Si), -2.8 (2 x CH3Si), 18.6 (2 x 
(C(CH3)3)), 19.1 (C6), 26.1 (C(CH3)3), 26.5 (C(CH3)3), 62.4, 62.5 (C1, C2), 68.4 (C4), 76.9 (C5), 79.8 
(C3), 102.2 (C7), 126.8, 128.6, 129.2, 138.6 (-Ar); m/z (ESI+ve): 530 ([M + Na]+, 100%). 
 
2-Azido-3-O-benzoyl-5-bromo-1,4-bis-(O-tert-butyldimethylsilyl)-2,5,6-trideoxy-L-glucitol 14 
N-Bromosuccinimide (146 mg, 0.83 mmol) and barium carbonate (205 mg, 1.04 mmol) were added 
into a solution of 29 (350 mg, 0.69 mmol) in carbon tetrachloride (5 mL). The reaction mixture was 
refluxed with stirring for 1 h until TLC (ethyl acetate/cyclohexane, 1:19) indicated the disappearance 
of the starting material (Rf 0.52) and the formation of one major product (Rf 0.71). After removing the 
solvent in vacuo, the residue was purified by flash column chromatography (ethyl acetate/hexane, 1:9) 
to afford the bromide 14 (400 mg, 99%) as a yellow oil.  
HRMS (ESI+ve): found 586.2127, 588.2105 [M + H]+; C25H45BrN3O4Si2+ requires 586.2127, 588.2106; 
[α]D25 -11 (c 0.66, CHCl3); vmax (thin film): 2098 (s, N3), 1728 (s, C=O); δH (400 MHz, CDCl3): 0.03 
(3H, s, CH3), 0.04 (3H, s, CH3), 0.08 (3H, s, CH3), 0.18 (3H, s, CH3), 0.86 (9H, s, 3 x CH3), 0.87 (9H, 
s, 3 x CH3), 1.74 (3H, d, H6, J6,5 6.9), 3.69 – 3.73 (1H, m, H2), 3.79 (1H, dd, H1, J1,2 7.0, Jgem 10.3), 
3.87 (1H, dd, H1’, J1’,2 4.9, Jgem 10.2), 4.26 (1H, t, H4, J4,3 = J4,5 5.0), 4.41 (1H, dq, H5, J5,4 4.8, J5,6 6.7), 
5.28 (1H, dd, H3, J3,2 3.7, J3,4 5.2), 7.46 (2H, t, -Ar, J 7.7), 7.60 (1H, t, -Ar, J 7.3), 8.08 – 8.10 (2H, m, 
-Ar); δC (100 MHz, CDCl3): -5.3 (2 x CH3Si), -3.9 (CH3Si), -3.8 (CH3Si), 18.5 (C(CH3)3), 18.6 
(C(CH3)3), 22.1 (C6), 26.1 (C(CH3)3), 26.2 (C(CH3)3), 49.5 (C5), 62.2 (C2), 63.8 (C1), 73.8 (C4), 75.9 
(C3), 128.6, 129.9, 130.4, 133.7 (-Ar), 165.9 (C=O); m/z (ESI+ve): 586, 588 ([M + H]+, 100%, 98%).  
 
3-O-Benzoyl-1,4-bis-(O-tert-butyldimethylsilyl)-2,5-imino-2,5,6-trideoxy-L-glucitol 30 
Palladium on charcoal (10 % wt., 60 mg) and sodium acetate (82 mg, 0.99 mmol) were added to a 
solution of the bromide 14 (385 mg, 0.66 mmol) in ethanol (20 mL). The solution was flushed with 
nitrogen, argon and hydrogen gas sequentially, and then stirred vigorously at rt under hydrogen 
atmosphere for 2 h until TLC (ethyl acetate/cyclohexane, 1:4) showed the formation of one major 
product (Rf 0.30). The reaction mixture was filtered, the solvent removed and the resultant crude product 
30 (400 mg) was used for the next step without further purification. A small portion of the crude material 
was purified for characterization by flash column chromatography (triethylamine/ethyl 
acetate/cyclohexane, 0.01:3:7) to afford 30 as a yellow oil. 
HRMS (ESI+ve): found 480.2955 [M + H]+; C25H45BrNO4Si2+ requires 480.2960; [α]D25 -13 (c 1.45, 
MeOH); vmax (thin film): 1723 (s, C=O); δH (CD3OD, 400 MHz): -0.09 (3H, s, CH3), 0.01 (3H, s, CH3), 
0.17 (3H, s, CH3), 0.26 (3H, s, CH3), 0.82 (9H, s, 3 x CH3), 0.99 (9H, s, 3 x CH3), 1.20 (3H, d, H6, J6,5 
6.6), 3.44 (1H, dq, H5, J5,4 3.5, J5,6 6.6), 3.74 – 3.85 (3H, m, H1, H1’, H2), 4.10 (1H, br-d, H4, J 2.0), 
5.39 (1H, br-d, H3, J 2.1), 7.52 (2H, t, -Ar, J 7.7), 7.65 (1H, t, -Ar, J 7.4), 8.08 (2H, d, -Ar, J 7.3); δC 
(CD3OD, 100 MHz): -4.6 (CH3Si), -4.5 (CH3Si), -4.1 (CH3Si), -3.6 (CH3Si), 15.5 (C6), 19.8 (C(CH3)3), 
19.7 (C(CH3)3), 27.1 (C(CH3)3), 27.2 (C(CH3)3), 58.3 (C5), 62.1 (C2), 63.3 (C1), 79.6 (C4), 81.5 (C3), 
130.5, 131.5, 132.2, 135.3 (-Ar), 167.7 (C=O); m/z (ESI+ve): 480 ([M + H]+, 100%). 
 
2,5-Imino-2,5,6-trideoxy-D-iditol 3 
The crude protected pyrrolidine 30 (400 mg) was dissolved in a solution of trifluoroacetic 
acid/water/1,4-dioxane (2:1:1, 10 mL). The solution was stirred at 50 °C for 24 h until mass 
spectrometry showed the deprotection of the silyl groups ([M + H]+ 252). The solvent was removed and 
the residue dissolved in sodium hydroxide solution (aq., 2M, 8 mL); the resulting solution was then 
stirred at 50 °C for 24 h until mass spectrometry showed the formation of the desired product ([M + H]+ 
148). The reaction mixture was neutralized with HCl (2M, aq) and the solvent removed in vacuo. The 
residue was dissolved in ethanol (5 mL) and filtered (glass microfiber) to afford a crude salt that was 
then loaded with water (~1 mL) onto a short column of DOWEX® 50WX8-200 resin. The ion exchange 
column was then washed with water, 1,4-dioxane and then water; the pure product was then eluted with 
aqueous ammonia (2 M). Removal of solvent in vacuo gave a residue which was subjected to a further 
purification cycle by resin column to give the title compound 3 (72 mg, 74% 3 steps from 14) as a 
yellow oil. 
HRMS (ESI+ve): found 148.0968 [M + H]+; C6H14N3O3+ requires 148.0968; [α]D25 +2.4 (c 0.17, water); 
vmax (thin film): 3300 (br, NH, OH); δH (D2O, 400 MHz): 1.15 (3H, d, H6, J6,5 6.7), 3.43 (1H, dq, H5, 
J5,4 3.7, J5,6 6.7), 3.05 (1H, ddd, H2, J2,3 4.9, J 2,1’ 6.6, J2,1 7.2), 3.65 (1H, dd, H1, J1,2 7.2, Jgem 11.4), 
3.77 (1H, dd, H1’, J1’,2 6.6, Jgem 11.4), 3.98 (1H, dd, H4, J4,3 1.5, J4,5 3.6), 4.24 (1H, dd, H3, J3,4 1.4, J3,2 
4.9); δC (D2O, 100 MHz): 13.2 (C6), 55.5 (C5), 60.7, 60.8 (C1, C2), 77.2 (C3), 78.9 (C4); m/z (ESI+ve): 
148 ([M + H]+, 100%).  
 
2-Azido-(R)-3,5-O-benzylidene-2,6-dideoxy-D-gulitol 31 
Lithium borohydride (2M in THF, 0.74 mL, 1.47 mmol) was added to a solution of lactone 11 (270 mg, 
0.98 mmol) in anhydrous THF at -20 °C. The reaction mixture was stirred at -20 °C for 2 h when TLC 
(ethyl acetate/cyclohexane, 2:1) showed the consumption of starting material (Rf 0.51) and the 
formation of a new spot (Rf 0.71). After addition of acetic acid (0.4 mL) to the mixture at -20 °C with 
stirring, the solvent was removed in vacuo to obtain a residue that was re-dissolved in ethyl acetate (20 
mL) and washed with water (20 mL). The aqueous layer was back extracted with ethyl acetate (2 x 15 
mL). The organic phase was combined, dried (MgSO4) and the solvent was removed in vacuo to yield 
a residue that was purified by flash column chromatography (ethyl acetate/cyclohexane, 1:2 to 2:1) to 
afford the diol 31 (246 mg, 90%) as a white solid. 
HRMS (ESI+ve): Found 302.1112 [M + Na]+; C13H17N3O4Na+ requires 302.1113; m.p.: 100 – 102 °C; 
[α]D25 +19 (c 0.69, CHCl3); vmax (thin film): 2102 (s, N3); δH (CDCl3, 400 MHz): 1.40 (3H, d, H6, J6,5 
6.4), 3.58 (1H, s, H4), 3.82 (1H, dd, H1, J1,2 4.9, Jgem 11.4), 3.85 (1H, d, H3, J3,2 9.1), 3.88 – 3.92 (1H, 
m, H4), 3.98 (1H, dd, H1’, J1’,2 3.2, Jgem 12.0), 3.90 (1H, ddd, H2, J2,1’ 3.1, J2,1 4.2, J2,3 8.5), 4.07 (1H, 
q, H5, J5,6 6.4), 5.60 (1H, s, H7), 7.37 - 7.48 (5H, m, -Ar); δC (CDCl3, 100 MHz): 17.5 (C6), 62.4, 62.5 
(C1, C2), 66.2 (C4), 76.9 (C5), 79.1 (C3), 101.5 (C7), 126.2, 128.7, 129.5, 137.6 (-Ar); m/z (ESI+ve): 
302 ([M + Na]+, 100%). 
 
2-Azido-(R)-3,5-O-benzylidene-1,4-bis-(O-tert-butyldimethylsilyl)-2,6-dideoxy-D-gulitol 32 
tert-Butyldimethylsilyl triflate (0.27 mL, 1.18 mmol) and anhydrous pyridine (0.11 mL, 1.41 mmol) 
were added to a solution of 31 (130 mg, 0.47 mmol) in anhydrous dichloromethane (6 mL) at 0 °C. The 
reaction mixture was stirred at rt for 15 h until TLC (ethyl acetate/cyclohexane, 1:9) showed the 
formation of a major spot (Rf 0.73). Removal of solvent in vacuo gave a residue that was dissolved in 
cyclohexane (20 mL) and washed with water (2 x 15 mL). The organic phase was dried (MgSO4), 
filtered and the solvent was removed to obtain a residue that was purified by flash column 
chromatography (ethyl acetate/cyclohexane, 1:9) to afford the silyl ether 32 (200 mg, 84%) as a 
colorless oil.  
HRMS (ESI+ve): found 530.2840 [M + Na]+; C25H45N3O4Si2Na+ requires 530.2841; [α]D25 +6.6 (c 0.80, 
CHCl3); vmax (thin film): 2103 (s, N3); δH (400 MHz, CDCl3): 0.04 (3H, s, CH3), 0.05 (3H, s, CH3), 0.14 
(3H, s, CH3), 0.17 (3H, s, CH3), 0.90 (9H, s, 3 x CH3), 0.99 (9H, s, 3 x CH3), 1.30 (3H, d, H6, J6,5 6.4), 
3.53 (1H, ddd, H2, J2,1’ 2.3, J2,1 4.9, J2,3 10.0), 3.66 (1H, s, H4), 3.76 (1H, d, H3, J3,2 10.0), 3.89 – 3.95 
(2H, m, H1, H5), 4.01 (1H, dd, H1’, J1’,2 2.4, Jgem 10.7), 5.51 (1H, s, H7), 7.32 - 7.47 (5H, m, -Ar); δC 
(100 MHz, CDCl3): -5.3 (CH3Si), -5.2 (CH3Si), -3.6 (CH3Si), -3.4 (CH3Si), 18.6 (C(CH3)3), 18.8 
(C(CH3)3), 22.3 (C6), 19.0 (C(CH3)3), 26.1 (C(CH3)3), 26.6 (C(CH3)3), 59.9 (C2), 63.2 (C1), 66.7 (C4), 




N-Bromosuccinimide (55 mg, 0.47 mmol) and barium carbonate (115 mg, 0.59 mmol) were added to a 
solution of 32 (200 mg, 0.39 mmol) in carbon tetrachloride (6 mL). The reaction mixture was refluxed 
for 1 h until TLC (ethyl acetate/cyclohexane, 1:19) indicated the disappearance of starting material (Rf 
0.70) and the formation of one major product (Rf 0.62). After removal of the solvent in vacuo, the 
residue was purified by flash column chromatography (ethyl acetate/hexane, 1:9) to give the manno-
bromide 15 (173 mg, 76%) as a yellow oil.  
HRMS (ESI+ve): found 586.2128, 588.2107 [M + H]+; C25H45BrN3O4Si2+ requires 586.2127, 588.2106; 
[α]D25 -8.1 (c 0.93, CHCl3); vmax (thin film): 2103 (s, N3), 1730 (s, C=O); δH (CDCl3, 400 MHz): -0.01 
(3H, s, CH3), 0.01 (3H, s, CH3), 0.21 (3H, s, CH3), 0.22 (3H, s, CH3), 0.87 (9H, s, 3 x CH3), 0.98 (9H, 
s, 3 x CH3), 1.69 (3H, d, H6, J6,5 6.9), 3.70 – 3.81 (2H, m, H1, H2), 3.86 (1H, dd, H1’, J1’,2 2.7, Jgem 
10.4), 4.16 (1H, dq, H5, J5,4 5.7, J5,6 6.7), 4.29 (1H, dd, H4, J4,3 1.7, J4,5 5.7), 5.41 (1H, dd, H3, J3,4 1.7, 
J3,2 9.2), 7.46 (2H, t, -Ar, J 7.6), 7.59 (1H, t, -Ar, J 7.5), 8.05 (2H, d, -Ar, J 7.3); δC (CDCl3, 100 MHz): 
-5.3 (2 x CH3Si), -3.9 (CH3Si), -3.8 (2 x CH3Si), 18.5 (C(CH3)3), 18.8 (C(CH3)3), 22.3 (C6), 26.1 
(C(CH3)3), 26.4 (C(CH3)3), 50.3 (C5), 61.9 (C2), 64.0 (C1), 71.9 (C3), 75.4 (C4), 128.9, 130.0, 130.3, 
133.7 (-Ar), 165.7 (C=O); m/z (ESI+ve): 586, 588 ([M + H]+, 100%, 98%).  
 
3-O-Benzoyl-1,4-bis-(O-tert-butyldimethylsilyl)-2,5-imino-2,5,6-trideoxy-D-gulitol 33 
Palladium on charcoal (10 % wt., 40 mg) and sodium acetate (49 mg, 0.60 mmol) was added to a 
solution of 15 (233 mg, 0.40 mmol) in ethanol (15 mL). The reaction mixture was flushed with nitrogen, 
argon and hydrogen gas sequentially. Then the reaction mixture was stirred vigorously at rt under 
hydrogen atmosphere for 5 h until TLC (ethyl acetate/cyclohexane, 1:4) showed the formation of one 
major product (Rf 0.14). Filtration  and evaporation to dryness in vacuo gave the crude protected 
pyrrolidine 33 (170 mg) which was used for the next step without further purification. A small portion 
was purified for characterization by flash column chromatography (triethylamine/ethyl 
acetate/cyclohexane, 0.01:2:1) to produce a pure sample of 33 as a yellow oil. 
HRMS (ESI+ve): found 480.2958 [M + H]+; C25H45BrNO4Si2+ requires 480.2960; [α]D25 -23 (c 0.90, 
MeOH); vmax (thin film): 1721 (s, C=O); δH (CD3OD, 400 MHz): 0.13 (6H, s, 2 x CH3), 0.15 (3H, s, 
CH3), 0.23 (3H, s, CH3), 0.93 (9H, s, 3 x CH3), 0.98 (9H, s, 3 x CH3), 1.23 (3H, d, H6, J6,5 6.6), 3.25 
(1H, dt, H2, J2,3 3.2, J2,1 = J2,1’ 6.0), 3.31 (1H, dq, H5, J5,4 3.5, J5,6 6.6), 3.85 (1H, dd, H1, J1,2 6.4, Jgem 
10.1), 3.92 3.85 (1H, dd, H1’, J1’,2 6.0, Jgem 10.1), 4.15 (1H, br-d, H4, J4,5 3.2), 5.19 (1H, br-d, H3, J3,2 
2.8), 7.52 (2H, t, -Ar, J 7.6), 7.65 (1H, t, -Ar, J 7.3), 8.06 (2H, d, -Ar, J 7.2); δC (CD3OD, 100 MHz): -
4.4 (CH3Si), -4.3 (CH3Si), -4.1 (CH3Si), -3.5 (CH3Si), 15.0 (C6), 19.9 (C(CH3)3), 20.0 (C(CH3)3), 27.2 
(C(CH3)3), 27.3 (C(CH3)3), 59.9 (C5), 65.3 (C2), 67.7 (C1), 80.9 (C4), 84.7 (C3), 130.5, 131.5, 132.0, 
135.3 (-Ar), 167.9 (C=O); m/z (ESI+ve): 480 ([M + H]+, 100%).  
 
2,5-Imino-2,5,6-trideoxy-D-gulitol [2,5-Imino-1,2,5-trideoxy-D-glucitol] 4 
A solution of the protected pyrrolidine 33 (170 mg) in trifluoroacetic acid/water/1,4-dioxane (2:1:1, 4 
mL) was stirred at 50 °C for 24 h until mass spectrometry showed the deprotection of the silyl groups 
([M + H]+ 252). The solvent was removed and the residue dissolved in sodium hydroxide solution (aq, 
2M, 3 mL) and stirred at 50 °C for 24 h until mass spectrometry showed the formation of desired product 
([M + H]+ 148). The mixture was neutralized with HCl (2M, aq) and the solvent removed in vacuo. The 
residue was dissolved in ethanol (5 mL) and filtered (glass microfiber) to afford a crude salt that was 
then loaded with water (~1 mL) onto a short column of DOWEX® 50WX8-200 resin. The ion exchange 
column was then washed with water, 1,4-dioxane and then water; the pure product was then eluted with 
aqueous ammonia (2 M). Removal of solvent in vacuo gave a residue which was subjected to a further 
purification by ion exchange column chromatography to yield the gulo-pyrrolidine 4 (30 mg, 51% 3 
steps from 15) as a light yellow gum. 
HRMS (ESI+ve): found 148.0968 [M + H]+; C6H14N3O3+ requires 148.0968; [α]D25 -8.9 (c 0.57, water) 
[lit.36 for 4L the enantiomer of 4: [α]D24 +17 (c 0.50, water)]; vmax (thin film): 3290 (br, NH, OH); δH 
(D2O, 400 MHz): 1.21 (3H, d, H6, J6,5 6.7), 3.13 (1H, ddd, H2, J2,3 4.4, J 2,1’ 4.9, J2,1 6.7), 3.45 (1H, dq, 
H5, J5,4 4.3, J5,6 6.7), 3.71 (1H, dd, H1, J1,2 7.0, Jgem 11.8), 3.80 (1H, dd, H1’, J1’,2 4.9, Jgem 11.8), 3.93 
(1H, dd, H3, J3,4 1.8, J3,2 4.4), 3.99 (1H, dd, H4, J4,3 1.8, J4,5 4.3); δC (D2O, 100 MHz): 12.6 (C6), 57.1 
(C5), 61.9 (C1), 66.7 (C2), 78.9 (C3), 79.4 (C4); m/z (ESI+ve): 148 ([M + H]+, 100%). 
 
5.5 Benzoyl protection: NGP in the Hanessian-Hullar reaction 
 
2-Azido-(R)-3,5-O-benzylidene-1,4-di-O-benzoyl-2,6-dideoxy-L-glucitol 36 
Benzoyl chloride (0.24 mL, 2.2 mmol) and pyridine (0.24 mL, 2.8 mmol) were added to a solution of 
the diol 22 (200 mg, 0.72 mmol) in anhydrous dichloromethane (7 mL). The reaction mixture was 
stirred at rt for 16 h until TLC (ethyl acetate/cyclohexane, 1:4) showed the formation of one major 
product (Rf 0.41). The solvent was removed in vacuo and the residue purified by flash column 
chromatography (ethyl acetate/cyclohexane, 1:19 to 1:4) to form the dibenzoate 36 (300 mg, 86%) as a 
clear oil; trituration of the oil with acetonitrile gave a white crystalline solid.  
HRMS (ESI+ve): found 510.1634 [M + Na]+; C27H25N3O6Na+ requires 510.1636; m.p. 111 - 114 °C; 
[α]D25 -29.6 (c 1.0, MeCN); vmax (thin film): 1716 (s, C=O), 2104 (s, N3); δH (CD3CN, 400 MHz): 1.58 
(3H, d, H6, J6,5 7.2), 4.14 - 4.21 (1H, m, H2), 4.35 (1H, dd, H1, J1,2 5.8, Jgem 12.1), 4.46 (1H, br-q, H5, 
J5,6 7.2), 4.50 (1H, dd, H1’, J1’,2 3.3, Jgem 12.1), 4.68 (1H, dd, H3, J3,4 1.4, J3,2 7.9), 5.02 (1H, br-s, H4), 
6.11 (1H, s, H7), 7.37 - 7.68 (10H, m, Ar x 2), 7.95 - 8.01 (2H, m, Ar), 8.09 - 8.15 (2H, m, Ar); δC 
(CD3CN, 100 MHz): 15.4 (C6), 60.8 (C2), 64.0 (C1), 69.8 (C4), 73.8 (C5), 74.5 (C3), 95.1 (C7), 127.3, 
129.2, 129.6, 129.7, 129.9, 130.4, 130.6, 130.9, 134.4, 134.5, 139.5 (-Ar), 166.7 (C=O), 166.8 (C=O); 
m/z (ESI+ve): 510 ([M + Na]+, 100%). 
 
2-Azido-5-bromo-1,3,4-tri-O-benzoyl-2,5,6-trideoxy-D-iditol 39 and 2-Azido-5-bromo-1,3,4-tri-O-
benzoyl-2,5,6-trideoxy-L-glucitol 40 
N-Bromosuccinimide (116 mg, 0.65 mmol) and barium carbonate (160 mg, 0.81 mmol) were added to 
a solution of 36A/B (265 mg, 0.54 mmol) in carbon tetrachloride (3.5 mL). The stirred reaction mixture 
was refluxed for 1 h until TLC (ethyl acetate/cyclohexane, 1:4) indicated the disappearance of starting 
material (Rf 0.39) and the formation of two products (Rf 0.45, 0.5). After removal of the solvent, the 
residue was purified by flash column chromatography (ethyl acetate/hexane, 0:10 to 1:4) to give a 
mixture of the inseparable epimeric bromides 39 and 40 (5:1, 280 mg, 91%) as a light yellow syrup.  
39: δH (CD3CN, 400 MHz): 1.76 (3H, d, H6, J6,5 6.8), 4.29 (1H, ddd, H2, J2,3 3.0, J2,1’ 5.2, J2,1 6.6), 4.35 
(1H, dd, H1, J1,2 6.6, Jgem 11.4), 4.63 - 4.71 (2H, m, H1’, H5,), 5.72 (1H, dd, H4, J4,5 3.1, J4,3 7.3), 5.95 
(1H, dd, H3, J3,2 3.1, J3,4 7.3), 7.39 - 7.72 (15H, m, -Ar x 3), δC (CD3CN, 100 MHz): 24.8 (C6), 50.4 
(C5), 60.9 (C2), 66.0 (C1), 75.4 (C3), 76.5 (C4), 130.9 – 136.1 (-Ar x 3), 167.7 (C=O), 167.8 (C=O), 
167.9 (C=O);  
40: δH (CD3CN, 400 MHz): 1.79 (3H, d, H6, J6,5 6.7), 4.20 (1H, dt, H2, J2,3 = J2,1’ 4.2, J2,1 6.2), 4.54 - 
4.71 (3H, m, H1, H1’, H5,), 5.89 (1H, t, H4, J4,5 = J4,3 5.4), 5.98 (1H, dd, H3, J3,2 4.5, J3,4 5.4), 7.39 - 
7.72 (15H, m, -Ar x 3), δC (CD3CN, 100 MHz): 22.9 (C6), 48.1 (C5), 62.3 (C2), 66.3 (C1), 73.4 (C3), 
77.4 (C4), 131.1 – 136.4 (-Ar x 3);  
 
1,3,4-Tri-O-benzoyl-2,5-imino-2,5,6-trideoxy-L-glucitol 41 and 1,3,4-Tri-O-benzoyl-2,5-imino-
2,5,6-trideoxy-D-iditol 42 
Palladium on charcoal (10 % wt., 30 mg) and sodium acetate (49 mg, 0.6 mmol) were added to a solution 
of the mixture of 39 and 40 (260 mg, 0.46 mmol) in ethanol (15 mL). The reaction mixture was flushed 
sequentially with nitrogen, argon and hydrogen and then stirred overnight at rt under a hydrogen 
atmosphere for 12 h when TLC (ethyl acetate/cyclohexane, 1:1) showed the formation of two products 
(Rf 0.14, 0.17). The solvent was removed and the residue purified by flash column chromatography 
(triethylamine/ethyl acetate/cyclohexane, 0.01:1:5 to 0.01:2:1) to afford a mixture of 5-epimers 41 and 
42 (4:1, 173 mg, 82%) as a white solid. The mixture was not clean enough for assignment of the 
tribenzoates by NMR; this crude product was directly used in the deprotection step. 
 
2,5-Imino-2,5,6-trideoxy-L-glucitol 1 and 2,5-Imino-2,5,6-trideoxy-D-iditol 3 
The mixture of 41 and 42 (100 mg, 0.22 mmol) was dissolved in sodium hydroxide (aq, 2M, 10 mL) 
and stirred at 50 °C for 48 h until mass spectrometry showed the formation of desired product ([M+H]+ 
148). The solvent was removed in vacuo; the residue was dissolved in ethanol (5 mL) and passed 
through glass fiber to afford a crude salt that was then loaded with water (~1 mL) onto a short column 
of DOWEX® 50WX8-200 resin. The ion exchange column was then washed with water, 1,4-dioxane 
and then water; the pure product was then eluted with aqueous ammonia (2 M). Removal of solvent in 
vacuo gave a mixture of the unprotected pyrrolidines 1 and 3 as a yellow oil (5 :1 according to 1H 
spectrum, 23 mg, 73%). 
 
2-Azido-(R)-3,5-O-benzylidene-1,4-di-O-benzoyl-2,6-dideoxy-L-mannitol 26 
Benzoyl chloride (0.12 mL, 1.1 mmol) and pyridine (0.12 mL, 1.4 mmol) were added into a solution of 
diol 25 (100 mg, 0.36 mmol) in anhydrous dichloromethane (7 mL). The mixture was stirred at rt for 
18 h until TLC (ethyl acetate/cyclohexane, 1:4) showed the formation of one major product (Rf 0.42). 
The solvent was in vacuo and the residue was purified by flash column chromatography (ethyl 
acetate/cyclohexane, 1:8 to 1:4) to afford the dibenzoate 26 (196 mg, 97%) as a white solid.  
HRMS (ESI+ve): found 510.1633 [M + Na]+; C27H25N3O6Na+ requires 510.1636; m.p. 79 - 85 °C; [α]D25 
+37.9 (c 1.0, MeCN); vmax (thin film): 2103 (s, N3), 1719 (s, C=O); δH (CD3CN, 400 MHz): 1.59 (3H, 
d, H6, J6,5 7.2), 4.23 (1H, ddd, H2, J2,1’ 2.7, J2,1 7.4, J2,3 9.7), 4.43 (1H, dd, H3, J3,4 1.5, J3,2 9.7), 4.50 
(1H, dd, H1, J1,2 7.4, Jgem 11.7), 4.51 (1H, dq, H5, J5,4 1.5, J5,6 7.2), 4.80 (1H, dd, H1’, J1’,2 2.7, Jgem 
11.7), 5.05 (1H, t, H4, J4,3 = J4,5 1.5), 6.01 (1H, s, H7), 7.34 - 7.69 (10H, m, -Ar x 2), 8.02 - 8.18 (4H, 
m, -Ar); δC (CD3CN, 100 MHz): 15.4 (C6), 60.7 (C2), 65.2 (C1), 69.3 (C4), 72.8 (C3), 73.7 (C5), 94.7 
(C7), 127.2, 129.2, 129.6, 129.7, 129.9, 130.47, 130.52, 130.7, 130.9, 134.3, 134.5, 139.4 (-Ar x 2), 
166.6, 166.8 (C=O); m/z (ESI+ve): 510 ([M + Na]+, 100%). 
 
2-Azido-1,3,4-tri-O-benzoyl-5-bromo-2,5,6-trideoxy-D-gulitol 43 and 2-Azido-1,3,4-tri-O-benzoyl-
5-bromo-2,5,6-trideoxy-L-mannitol 44 
N-Bromosuccinimide (156 mg, 0.88 mmol) and barium carbonate (217 mg, 1.1 mmol) were added into 
a solution of 26 (357 mg, 0.73 mmol) in carbon tetrachloride (5.0 mL). The mixture was refluxed with 
stirring for 1 h until mass spectrometry indicated the completion of reaction ([M + Na]+ 588, 590) The 
solvent was removed in vacuo and the residue purified by flash column chromatography (ethyl 
acetate/hexane, 1:9 to 3:7) to give a mixture of the bromide epimers 43 and 44 (4:1, 388 mg, 94%) as a 
colorless oil. Separation of the epimers 43 and 44 by flash column chromatography was not efficient. 
HRMS (ESI+ve): found 588.0740, 590.0719; C27H24BrN3O6Na+ requires 588.0741, 590.0720; vmax (thin 
film): 2108 (s, N3), 1722 (s, C=O); m/z (ESI+ve): 588, 590 ([M + Na]+, 100%, 95%) 
43: δH (CD3CN, 400 MHz): 1.76 (3H, d, H6, J6,5 6.8), 4.31 (1H, dt, H2, J2,1’ 3.7, J2,1 = J2,3 6.7), 4.46 
(1H, dd, H1, J2,1 6.7, Jgem 12.0), 4.55 - 4.63 (1H, m, H5), 4.70 (1H, dd, H1’, J1’,2 3.7, Jgem 12.0), 5.72 
(1H, t, H4, J4,3 = J4,5 5.0), 5.78 (1H, dd, H3, J4,3 5.0, J3,2 6.7), 7.41 - 7.71 (9H, m, -Ar), 7.95 - 7.17 (6H, 
m, -Ar); δC (CD3CN, 100 MHz): 23.1 (C6), 49.4 (C5), 61.0 (C2), 64.3 (C1), 72.4 (C3), 75.1 (C4), 129.6-
130.8, 134.5, 134.7, 134.8 (-Ar), 166.1 (C=O), 166.4 (C=O), 166.7 (C=O). 
44: δH (CD3CN, 400 MHz): 1.72 (3H, d, H6, J6,5 6.7), 4.25 (1H, ddd, H2, J2,1’ 3.7, J2,1 6.7, J2,3 7.8), 4.42 
(1H, dd, H1, J1,2 6.7, Jgem 11.9), 4.41 - 4.49 (1H, m, H5), 4.63 (1H, dd, H1’, J2,1’ 3.7, Jgem 11.9), 5.82 
(1H, dd, H4, J3,4 2.7, J4,5 7.7), 5.87 (1H, dd, H3), 7.41 - 7.71 (9H, m, -Ar), 7.95 - 7.17 (6H, m, -Ar); δC 
(CD3CN, 100 MHz): 22.1 (C6), 46.8 (C5), 61.1 (C2), 64.4 (C1), 71.2 (C3), 75.5 (C4), 129.6 - 130.8, 
134.4, 134.87, 134.92 (-Ar), 166.1 (C=O), 166.4 (C=O), 166.6 (C=O). 
 
1,3,4-Tri-O-benzoyl-2,5-imino-2,5,6-trideoxy-L-mannitol 45 and 1,3,4-Tri-O-benzoyl-2,5-imino-
2,5,6-trideoxy-D-gulitol 46 
Palladium on charcoal (10 % wt., 73 mg) and sodium acetate (84 mg, 0.6 mmol) were added to a solution 
of 43 and 44 (388 mg, 0.69 mmol) in ethanol (15 mL). The reaction mixture was flushed sequentially 
with nitrogen, argon and hydrogen, stirred at rt under hydrogen atmosphere for 16 h until TLC (ethyl 
acetate/cyclohexane, 3:7) showed the formation of two products (Rf 0.12, 0.14). The solvents were 
removed in vacuo and the residue was purified by flash column chromatography (triethylamine/ethyl 
acetate/ petroleum ether, 0.01:1:8 to 0.01:2:1) to obtain a mixture of 5-epimers 45 and 46 (10:7, 280 
mg, 89%) as a yellow oil. Attempted separation of 45 and 46 by flash column chromatography was not 
successful. 
45: δH (CD3CN, 400 MHz): 1.34 (3H, d, H6, J6,5 6.6), 3.57 (1H, br-dq, H5, J5,4 4.2, J5,6 6.6), 3.82 (1H, 
dt, H2, J2,3 4.2, J2,1 = J2,1’ 5.6), 4.50 (1H, dd, H1, J1,2 5.6, Jgem 10.9), 4.53 - 4.60 (1H, m, H1’), 5.72 (1H, 
dd, H4, J4,3 3.7, J4,5 4.2), 5.58 (1H, dd, H3, J3,4 3.7, J3,2 4.1), 7.34 – 7.78 (15H, -Ar x 3); δC (CD3CN, 
100 MHz): 20.3 (C6), 60.2 (C5), 63.4 (C2), 67.7 (C1), 83.4 (C3), 86.9 (C4), 120.7 – 135.8 (-Ar x 3), 
168.0 (C=O), 168.1 (C=O), 168.4 (C=O). 
46: δH (CD3CN, 400 MHz): 1.21 (3H, d, H6, J6,5 6.3), 3.61 – 3.68 (2H, m, H2, H5), 4.45 – 4.60 (2H, m, 
H1, H1’), 5.42 (1H, dd, H4, J 1.9, J 4.9), 4.48 (1H, dd, H3, J 1.9, J 4.5), 7.34 – 8.08 (15H, m, -Ar x 3); 
δC (CD3CN, 100 MHz): 16.0 (C6), 58.6 (C5), 64.8 (C2), 67.6 (C1), 82.8 (C3), 83.3 (C4), 120.7 – 135.8 
(-Ar x 3), 167.8 (C=O), 167.9 (C=O), 168.3 (C=O). 
 
2,5-Imino-2,5,6-trideoxy-L-mannitol 2 and 2,5-Imino-2,5,6-trideoxy-D-gulitol 4 
The epimeric mixture of the tribenzoates 45 and 46 (200 mg, 0.44 mmol) was dissolved into sodium 
hydroxide solution (aq., 2 M, 15 mL) and stirred at 50 °C for 48 h until mass spectrometry showed the 
formation of desired product ([M + H]+ 148). The solvent was removed in vacuo, the residue was 
dissolved in ethanol (5 mL) and filtered (glass fiber) to afford a crude salt that was then loaded with 
water (~1 mL) onto a short column of DOWEX® 50WX8-200 resin. The ion exchange column was then 
washed with water, 1,4-dioxane and then water; the pure product was then eluted with aqueous 
ammonia (2 M). Removal of solvent in vacuo yielded a mixture of 2 and 4 as a yellow oil (5:3 according 
to 1H spectrum, 46 mg, 70%). 
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